MOHS Analytics expands health, wellness offerings

MANILA, Philippines — MOHS Analytics, a fast-growing company that provides quality health and wellness solutions through technology, is expanding its line of test kits for various diseases, with over 2,500 drugstores all over the country already offering its affordable kits to test for COVID-19, urinary tract infection, dengue and malaria.

The company broke into the health industry at the height of the COVID pandemic. It was one of the first to introduce rapid antigen tests to the Philippine market, making home testing as close as the nearest drugstore.

MOHS Diagnostics has also introduced an ovulation test kit, which will be a helpful tool for women who want to get pregnant. Under development is a test for leptospirosis.

“In the first semester of 2023, MOHS Analytics revenues increased by 37 percent compared to the first semester of 2022 while gross profit grew by 30 percent.  Net profit after tax recorded an even greater increase by growing by 35 percent for the same period,” said MOHS CFO Dr. Kenji Asano Jr.

“Our financial results show that Filipinos have accepted home test kits as an important tool in managing their health,” added MOHS CEO Mike Hortaleza. “There is a growing realization that disease detection can be quickly and accurately done at home such that the sick can start early treatment and preventing the spread of disease.”